Selloff or Market Correction? Either Way, Here's What to Do NextSee Overvalued Stocks

2 WallStreetBets Healthcare Stocks to Avoid

Published 04/29/2021, 03:51 PM
Updated 04/29/2021, 04:30 PM
© Reuters.  2 WallStreetBets Healthcare Stocks to Avoid
GME
-

The share prices of companies in in the healthcare sector have skyrocketed over the past year due to the heightened need for their products and services. However, some stocks were able to achieve price highs due solely to a short squeeze triggered by Reddit’s WallStreetBets (WSB) forum. For example, despite possessing weak financials, Clover Health (CLOV) and COMPASS Pathways (CMPS) witnessed solid gains thanks to the actions of WBS. Both stocks have lost some value lately, and we think that they do not have the potential to rebound. So, they are best avoided now.The entire healthcare sector, ranging from drugstores to biotech companies, strived to survive the COVID-19 pandemic by inventing vaccines and fulfilling urgent market demand for protection equipment and safe healthcare facilities, for example. And because several countries are now experiencing a resurgence of COVID-19 infections, the healthcare sector is expected to play a significant role this year again. In fact, the sector has immense potential to grow beyond this year thanks to technological advancements and a growing need for better healthcare products and facilities. The global healthcare IT market is projected to grow at a 14% CAGR over the next eight years.

Vanguard Health Care Index Fund ETF’s (VHT) 27.8% returns over the past year reflect significant investor interest in the sector. However, not all stocks in this space have gained because of a favorable industry backdrop. Reddit’s WallStreetBets (WSB)—which captured headlines thanks to its participants' huge success in squeezing short sellers out of their positions in GameStop (NYSE:GME) earlier this year—gamed weak players with high short interest in the healthcare space too.

But WBS favorites Clover Health Investments, Corp. (CLOV) and COMPASS Pathways plc (CMPS) have lost significant value lately and could witness further declines. Given their high valuations versus their financial strength, or lack thereof, we think that these stocks are best avoided now.

Continue reading on StockNews

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.